SK Biopharmaceuticals.
₩86,600
1
+₩200+0.23% Friday 06:30
Statistics
Day High
86,600
Day Low
86,600
52W High
144,100
52W Low
73,000
Volume
-
Avg. Volume
-
Mkt Cap
6.78T
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
5NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
235.93
727.46
1,218.99
1,710.53
Expected EPS
586.188492117
Actual EPS
N/A
Financials
37.77%Profit Margin
Profitable706.74BRevenue
266.95BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
SK Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the research, identification, and development of novel therapies for central nervous system (CNS) disorders. Their product portfolio features Cenobamate, indicated for the treatment of epilepsy, and Solriamfetol, which addresses excessive daytime sleepiness experienced in conditions like narcolepsy or obstructive sleep apnea. The company's robust clinical pipeline includes Carisbamate, currently in Phase 1b/2 trials for Lennox-Gastaut syndrome, and Relenopride, advancing through Phase 2 for a rare neurological disease. Additionally, they have several candidates in Phase 1 development: SKL13865 for attention deficit/hyperactivity disorder (ADHD), SKL20540 for schizophrenia, SKL-PSY for bipolar disorder, and SKL24741, another potential treatment for epilepsy. Founded in 2011, the company is headquartered in Seongnam, South Korea, and functions as a subsidiary of SK Inc.
Show more...
CEO
Dong Hoon Lee
Employees
241
Country
South Korea
ISIN
KR7326030004
Listings
0 Comments
Share your thoughts
FAQ
What is SK Biopharmaceuticals. stock price today?▼
The current price of 326030.KQ is ₩86,600 KRW — it has increased by +0.23% in the past 24 hours. Watch SK Biopharmaceuticals. stock price performance more closely on the chart.
What is SK Biopharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange SK Biopharmaceuticals. stocks are traded under the ticker 326030.KQ.
Is SK Biopharmaceuticals. stock price growing?▼
326030.KQ stock has fallen by -1.59% compared to the previous week, the month change is a +5.61% rise, over the last year SK Biopharmaceuticals. has showed a -20.7% decrease.
What is SK Biopharmaceuticals. market cap?▼
Today SK Biopharmaceuticals. has the market capitalization of 6.78T
When is the next SK Biopharmaceuticals. earnings date?▼
SK Biopharmaceuticals. is going to release the next earnings report on November 05, 2026.
What were SK Biopharmaceuticals. earnings last quarter?▼
326030.KQ earnings for the last quarter are 530.5 KRW per share, whereas the estimation was 530.5 KRW resulting in a +0% surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is SK Biopharmaceuticals. revenue for the last year?▼
SK Biopharmaceuticals. revenue for the last year amounts to 706.74B KRW.
What is SK Biopharmaceuticals. net income for the last year?▼
326030.KQ net income for the last year is 266.95B KRW.
How many employees does SK Biopharmaceuticals. have?▼
As of September 05, 2026, the company has 241 employees.
In which sector is SK Biopharmaceuticals. located?▼
SK Biopharmaceuticals. operates in the Health & Wellness sector.
When did SK Biopharmaceuticals. complete a stock split?▼
SK Biopharmaceuticals. has not had any recent stock splits.
Where is SK Biopharmaceuticals. headquartered?▼
SK Biopharmaceuticals. is headquartered in Seongnam-si, South Korea.